Artal Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,800
| Closed | -$4.96M | – | 146 |
|
|
2021
Q4 | $4.96M | Hold |
41,800
| – | – | 0.13% | 97 |
|
|
2021
Q3 | $8.31M | Hold |
41,800
| – | – | 0.19% | 85 |
|
|
2021
Q2 | $7.27M | Hold |
41,800
| – | – | 0.15% | 103 |
|
|
2021
Q1 | $8.28M | Hold |
41,800
| – | – | 0.15% | 94 |
|
|
2020
Q4 | $8.22M | Hold |
41,800
| – | – | 0.18% | 86 |
|
|
2020
Q3 | $7.41M | Sell |
41,800
-2,200
| -5% | -$390K | 0.18% | 73 |
|
|
2020
Q2 | $10.2M | Buy |
44,000
+28,000
| +175% | +$6.48M | 0.28% | 56 |
|
|
2020
Q1 | $1.86M | Buy |
16,000
+4,000
| +33% | +$466K | 0.08% | 86 |
|
|
2019
Q4 | $2.29M | Hold |
12,000
| – | – | 0.09% | 80 |
|
|
2019
Q3 | $2.31M | Buy |
12,000
+5,242
| +78% | +$1.01M | 0.09% | 82 |
|
|
2019
Q2 | $1.16M | Buy |
+6,758
| New | +$1.16M | 0.05% | 87 |
|